MRCHF.US H.U. Group Holdings Inc

Healthcare Biotechnology USA Stocks
25.00 USD
Close of Nov 15, 2026
17.96 25.00
Market cap
USD 1.35B
P/E
21.9x
P/B
1.65x
ROE
5.1%
Dividend yield
3.14%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is MRCHF.US undervalued?

Graham number
Price25.00
Graham value19.71
Premium26.8%

MRCHF.US trades 26.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

H.U. Group Holdings Inc fundamental analysis

No fundamental analysis for H.U. Group Holdings Inc yet.

H.U. Group Holdings Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About H.U. Group Holdings Inc

H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment provides general testing services to medical institutions that include esoteric testing, such as genetic and oncology testing; diagnostics-related tests for cancer treatment; omics analysis comprising whole genome sequencing (WGS) and proteome analysis; support for clinical trials an…

Full company profile